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(57)	 ABSTRACT
Method and system for detecting presence of biomolecules in
a selected subset, or in each of several selected subsets, in a
fluid. Each of an array of two or more carbon nanotubes
("CNTs") is connected at a first CNT end to one or more
electronics devices, each of which senses a selected electro-
chemical signal that is generated when a target biomolecule in
the selected subset becomes attached to a functionalized sec-
ond end of the CNT, which is covalently bonded with a probe
molecule. This approach indicates when target biomolecules
in the selected subset are present and indicates presence or
absence of target biomolecules in two or more selected sub-
sets. Alternatively, presence of absence of an analyte can be
detected.
21 Claims, 5 Drawing Sheets
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Provide at least first and second sub-arrays
	 31
of CNTs, with first ends connected to
first and second electronics devices,
respectively
Provide electrically insulating material in
	 32
interstitial space between first and
second sub-array CNTs
Remove excess insulating material to expose
second ends of first and second
sub-array CNTs
Passivate exposed surfaces of electronics
devices (optional)
Functionalize second end of first sub-array CNT
and second end of second sub-array CNT to
permit attachment of first subset and of second
subset of first class biomolecule to functionalized
second ends of first sub-array CNT and second
sub-array CNT, respectively
To Step 36
	
To Step 39
Fig. 3A
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From Step 35	 From Step 34
Expose second ends of first sub-array CNT and
second sub-array CNT to a fluid that may
contain one or more biomolecules from
the first subset and/or from the second
subset of second class biomolecule
37
Interpret appearance of a first signal S1 in the
first electronics device as indicating presence
of a first subset biomolecule in the fluid (optional)
38
Interpret appearance of a second signal S2
in the second electronics device as indicating
presence of a second subset biomolecule
in the fluid (optional)
39
Interpret appearance of a third signal S3
in the corresponding electronics device as
indicating presence of an analyte
in the fluid (optional)
Fig. 3B
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BIOCHEMICAL SENSORS USING CARBON
NANOTUBE ARRAYS
ORIGIN OF THE INVENTION
This invention was made, in whole or in part, by one or
more employees of the U.S. Government, which has the right
to make, use and/or sell the invention without payment of
royalties therefor.
FIELD OF THE INVENTION
This invention relates to sensing of presence and amount of
specific chemical and biological molecules.
BACKGROUND OF THE INVENTION
The clinical laboratory is experiencing a revolution in
reducing the cost and time required for molecular diagnostics.
This development is increasingly important for implementing
aspects of the Human Genome Project. A lack of procedures
for quickly, accurately and inexpensively detecting presence
of specific molecular signatures has become a bottleneck
limiting use of relevant genetic information. Presently,
molecular diagnostics is highly labor-intensive, with little
automation or integration. Miniaturization technologies that
integrate engineering capabilities and microelectromechani-
cal systems (MEMS) with molecular biology expertise would
allow molecular signature tests to be performed in micro-
chips.
What is needed is an approach for quickly and accurately
detecting presence of specific biological molecules ("biomol-
ecules") that are of concern in molecular biology and related
chemistry disciplines. Preferably, the procedure should allow
detection of a specific molecule and/or of a class of related
molecules, should be flexible, and should permit automation
and integration of the procedure with other related biological
and chemical procedures.
SUMMARY OF THE INVENTION
These needs are met by the invention, which provides an
array of carbon nanotubes, each with a first end electrically
connected to an electronics device, and with a second (ex-
posed) end being functionalized with a selected molecule
attached thereto that provides an electrochemical or other
signal that is recognized by the electronics device.
A novel biosensor platform and relevant electrochemical
detection methods are developed using a vertically aligned
carbon nanotube array, with nanoelectrodes embedded in
dielectric materials such as SiO , Si 3N4 or suitable polymers.
The dielectric encapsulation provides mechanical robustness
and electrical isolation of the individual nanoelectrodes.
A first end of each carbon nanotube is attached to one or
more metal electrodes or contacts, and a portion of a second
end of a carbon nanotube is exposed at the surface of the
dielectric layer and is covalently functionalized with one or
more biomolecule probes, such as oligonucleotides, peptides,
proteins, enzymes, etc. through the formation of amide
bonds. One, two or more different sub-arrays of functional-
ized CNT ends are provided, where each sub-array consists of
a type of biomolecule that can specifically bind with a bio-
molecule marker in the sample solution that is associated with
a particular genetic sequence of disease or condition, or is
linked with enzymes that can catalyze a specific reaction.
The binding of the target molecules (biomolecule mark-
ers), through specific interaction with the probe molecules
2
functionalized at the CNT ends, is to be detected by electro-
chemical methods. This technique can be implemented
through disposable cartridges in hand-held devices or work
stations for quick identification of biomarkers. This approach
5 can be also used as a detector to enhance the performance of
other systems such as separation instruments including chro-
matography or microfluidics devices.
Electrochemical methods are attractive for development of
biosensors because such a sensor can directly interface the
io biomolecules in physiological environments with microelec-
tronics circuits. The sample handling, signal processing, and
device fabrication can be dramatically simplified by use of
mature microfabrication techniques. However, the sensitivity
is normally lower than other techniques such as laser fluores-
15 cence. By introducing embedded carbon nanotube nanoelec-
trode array on top of the multiplex microelectrodes, it pro-
vides the following advantages: (1) much smaller number of
target molecules required (since the active surface area is only
a very small fraction of the microelectrode surface), (2) fast
20 detection due to much higher temporal resolution, (and make
it possible to use advanced pulsed electronic techniques such
as differential pulse voltammetry, AC voltammetry, square-
wave voltammetry, electrochemical impedance spectroscopy
(EIS), etc. in addition to conventional cyclic voltammetry,
25 potentiometry, amperometry, etc.), and (3) much higher sen-
sitivity as a result from (1) and (2). In addition, catalytic
mediators can be added to the buffer solutions so that the
electrochemical signal can be amplified further.
Previous studies may have used similar catalytic mediators
30 or enzymatic mechanisms, but are limited by the poor signal-
to-noise ratio associated with the large solid electrode diam-
eter (typically>30 microns), poor stability (due to weak bind-
ing of organic films on electrode surface) and/or small
potential windows for the electrode materials. By compari-
35 son, carbon nanotubes are biocompatible, have a wide poten-
tial window, and can be selectively functionalized through
strong covalent binding. Many functional groups in biomol-
ecules, such as guanine bases, can be directly measured with
carbon nanotube electrodes. The nanoscale electrode size can
4o dramatically improve the performance in terms of sensitivity
(i.e., signal-to-background ratio and signal-to-noise ratio),
temporal resolution, and stability.
The innovation includes the following technical features.
(1) Using vertical aligned carbon nanotube nanoelectrode
45 arrays as the sensing element: The CNTs efficiently intercon-
nect biomolecules with electronic circuits, and the sidewalls
and circuits are encapsulatedby insulating dielectrics to mini-
mize the background noise. A method is developed to control
the density of active carbon nanotube nanoelectrodes by
50 lithography or controlling the endpoints of chemical
mechanical polishing, plasma etching and/or chemical etch-
ing. A separation over at least six times of the radius of each
nanoelectrode is desired to avoid the overlapping of the dif-
fusion layers around neighboring electrodes.
55 (2) Functionalization and/or passivation (optional): An
electrochemical etching step in NaOH solution is developed
to prepare a well-defined —COOH rich carbon nanotube end
for reliable functionalization through amide bonds, which is
highly selective to carbon materials. The rest of the surface is
60 passivated with poly ethylene glycol molecules through
silane chemistry. This ensures that active probe molecules
only attach to the desired active CNT sites. Alternatively,
portions of the matrix surface (insulating material) can be
functionalized instead of functionalization of the CNT sites.
65 (3) Electrochemical detection: Pulsed electrochemical
techniques such as differential pulse voltametry, AC voltam-
etry, square-wave voltametry, electrochemical impedance
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spectroscopy, fast scan cyclic voltammetry, etc. can be
employed in addition to conventional cyclic voltammetry,
potentiometry, amperometry for appropriate sensor applica-
tion for improving sensitivity.
(4) A separate electrode or subsequent measurements on 5
the same electrode (for irreversible reactions) can be used as
control to ensure the correct measurements.
Apotential benefit ofbiosensors based on carbon nanotube
nanoelectrode arrays is the dramatically improved sensitivity
and reliability. Such features can enable the realization of 10
many other advantages of electronic techniques such as min-
iaturization, multiplexing, low cost, simple operation, and
quick detection, which are highly demanded for quick bio-
molecular analysis. It may find applications in space pro-
gram, homeland protection, environmental monitoring, 15
point-of-care, early disease diagnosis, and biomedical treat-
ments. The detection technique may be also used in other
analytical instruments such as chromatography and microf-
luidics, with or without functionalization of the exposed CNT
ends with biomolecules. 	 20
BRIEF DESCRIPTION OF THE DRAWINGS
FIGS. 1A-1G schematically illustrate fabrication of an
array of CNTs on a substrate.	 25
FIG. 2 schematically illustrates apparatus for practicing
the invention.
FIG. 3 is a flow chart of a procedure for practicing the
invention.
30
DESCRIPTION OF BEST MODES OF THE
INVENTION
A carbon nanotube (CNT) is a regular geometric structure
of covalently connected C atoms, such as a cylindrical struc-  35
ture with a substantially constant or variable diameter that
may range from 1 nanometer (nm) to tens or hundreds of mu,
resembling a hollow tube. A CNT is normally grown from,
and oriented approximately perpendicular to, a substrate with
a specially prepared surface and can reach a vertical height of 40
100 nm to 20 µm, or higher, before the structure begins to
"droop" and depart from a vertical orientation. The structure
may have a single layer or a multiple layer of C atoms. An
exposed end of a C atom chain may be functionalized to bond
to a class of other molecules. 	 45
A CNT can be fabricated using a procedure such as the
following, illustrated in FIGS. 1A-1F. A metal film, such as
Cr, Pt, Pd, Ti, and/or Mo, typically about 200 µm thick, is
deposited onto a Si wafer that is covered with about 500 nm of
S'02 or Si3N4 (FIG. 1A). The metal film serves as an electrical 50
contact that can be patterned as desired. A Ni catalyst film of
thickness 10-30 nm is deposited at one or more desired (pat-
tern) locations on the metal contact (FIG. 113). The Ni film at
each location can be patterned as an array of dots, each having
a diameter no greater than 100 mu, or as one or more spots 55
having a diameter from less than 1 µm to hundreds of µm, or
as a continuous film over the entire pattern. A vertically
aligned multiwall CNT array is grown on the Ni catalyst,
using plasma enhanced chemical vapor deposition (PECVD,
FIG. 1C). A film of S'02 with thickness 2-5 µm is deposited 60
using thermal CVD of tetraethylorthosilicate (TEOS) at a
temperature T=650-750° C. and TEOS vapor pressure 400
mTorr, providing a conformal film that encapsulates each
CNT and the substrate surface (FIG. 1D). The extra S'02 at
the top surface of the substrate is removed by chemical/ 65
mechanical polishing (CMP), mechanical polishing, chemi-
cal etching, plasma etching or a similar process, so that one
4
end of some of the CNTs is exposed (FIG. 1E). Electrochemi-
cal measurements are performed on the product, for example,
using a three-electrode configuration (FIG. 1F). FIG. 1G (not
drawn to scale) schematically illustrates a result of the pro-
cess steps shown in FIG. 1A-113 for patterned multiple metal
contacts.
FIG. 2 schematically illustrates a system 21 incorporating
the invention. A first sub-array 22-1 and a second sub-array
22-2 of vertically oriented CNTs, having respective first sub-
array electrodes 23-1 and second sub-array electrodes 23-2,
are electrically connected to a first signal processing device
24-1 and to a second signal processing device 24-2, respec-
tively, at first ends 22e1-1 and 22e2-1 of the CNTs. The first
sub-array 22-1 of CNTs and the second sub-array 22-2 of
CNTs may be intermingled with each other or may be spaced
apart from and isolated from each other. Interstitial space
between adjacent CNTs, whether from the same sub-array or
from a different sub-array, is partly or wholly filled with an
insulating material 25, such as SiO, or SiyN, or suitable poly-
mers, to reduce or eliminate cross-talk or other electromag-
netic interference between two adjacent (or non-adjacent)
CNTs. The insulating material 25 is processed, by mechani-
cal polishing, by chemical mechanical polishing (CMP), by
plasma etching, by wet chemical etching, or by another suit-
able technique, so that a second end 22e1-2 of the first sub-
array 22-1 of CNTs and a second end 22e2-2 of the second
sub-array 22-2 of CNTs is eitherfully exposed or is flushwith
an exposed surface 25s of the insulating material.
A second end 22e1-2 of each CNT in the first sub-array
22-1 is functionalized so that a first subset of biomolecules
26-1 from a first class of biomolecules (probe molecules) can
attach itself to the second end 22e1-2 of the first sub-array
CNT. A second end 22e2-2 of each CNT in the second sub-
array 22-2 is functionalized so that a second subset of bio-
molecules 26-2 from the first class of biomolecules can attach
itself to the second end 22e2-2 of the second sub-array CNT.
Preferably, the first and second subsets of the first class of
biomolecules (probe molecules) are confined exclusive to the
respective sub-arrays 22-1 and 22-2 so that no first subset
biomolecule can attach itself to the second end 22e2-2 of a
member of the second CNT sub-array 22-2, and no second
subset biomolecule can attach itself to the second end 22e1-2
of a member of the first CNT sub-array 22-1.
A fluid 28, which may or may not include biomolecules
from the second class of biomolecules (target molecules), is
positioned contiguous to, or flows through, the functionalized
second ends, 22e1-2 and 22e2-2, which initially have biomol-
ecules from the first class attached thereto. Each biomolecule
from a first subset of the second class specifically bonds only
with a particular subset biomolecule from the first class. If, for
example, the fluid 28 contains biomolecules from the first
subset of the second class, some of these biomolecules will
attach themselves to the first subset of the first class of bio-
molecules of functionalized second ends 22e1-2 of the first
sub-array CNTs, and this will produce an electromagnetic
signal Sl that is received and sensed by the first signal pro-
cessing device 24-1. Similarly, if the fluid 28 contains bio-
molecules from the second subset from the second class,
some of these biomolecules will attach themselves to the
second subset of the first class of biomolecules of the func-
tionalized second ends 22e2-2 of the second sub-array CNTs,
and this will produce an electromagnetic signal S2 that is
received and sensed by the second signal processing device
24-2 (which, optionally, may coincide with the first signal
processing device 24-1). The signals Sl and S2 may be the
same or may be different.
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In this version, it is assumed that only the presence of a 	 end of the second sub-array CNT allows a biomolecule from
sufficient density or absolute number of the first subset of	 a second subset of the first biomolecule class to attach itself to
target biomolecule will produce a signal Sl, and only the	 this second end of the second sub-array CNT, if the second
presence of a sufficient density or absolute number of the 	 subset biomolecule is present in a fluid medium to which the
second subset of target biomolecule will produce a signal S2, 5 second end of the second sub-array CNT is exposed. Func-
whether Sl is the same as S2 or different from S2. If the	 tionalization is preferably performed sequentially by activat-
signals Sl and S2 differ substantially from each other, the first	 ing a sub-array of CNTs with electrochemical etching, then
signal processing device 24-1 and the second signal process- 	 introducing a specific subset of biomolecules. This process
ing device 24-2 can be the same device, and the distinction	 can also be performed by applying a specific subset of the first
between the signals Sl and S2 is made within this device. 	 io class of molecules at specific sub-array sites.
In some applications, functionalization of the first class of
	
In step 36, the (functionalized) second ends of the first
biomolecules (probe molecules) may be deleted. In this 	 sub-array CNT and the second sub-array CNT and the insu-
approach, a third class of molecules, referred to as analytes 	 lating material are exposed to a fluid that may contain the a
(not necessarily having specific biorecognition properties), 	 biomolecule from the second class. If and only if the fluid
may be introduced into the fluid 28. The third class may be 15 contains the first subset of the second class biomolecule (tar-
biomolecules or other molecules. Where an analyte is used,	 get biomolecule) with a sufficient density or amount, a signal
functionalization of exposed second ends of CNTs need not 	 Sl will be sensed by the first electronics device. If and only if
be performed. An analyte may allow or facilitate production	 the fluid contains the second subset of the second class bio-
of a third signal S3 in a corresponding electronics device. In	 molecule (target biomolecule) with a sufficient density or
step 38 (optional), appearance of a fourth electromagnetic 20 amount, a signal S2 will be sensed by the second electronics
signal S4 in the second electronics device is interpreted as	 device. If and only if the fluid contains a specific analyte, a
indicating that the second subset of the third class of molecule 	 third signal S3 is sensed by the corresponding electronics
is present in the fluid.	 device.
FIG. 3 is a flow chart illustrating a procedure for construct- 	 Each subset of the first class biomolecule may be chosen
ing a system for practicing the invention. In step 31, an array 25 from a class of oligonucleotides, peptides, proteins and/or
of at least two CNTs is provided. A first end of each CNT in 	 enzymes. The second class biomolecule may be an oligo-
a first sub-array is electrically connected to a first electronics	 nucleotide, a segment of DNA, RNA, protein, bacterium or
device that provides a first electromagnetic signal Sl when a	 non-biological substance that undergoes strong bonding with
first biomolecule becomes connected to a CNT in the first 	 the first class biomolecule.
sub-array. A first end of each CNT in a second sub-array is 30	 Preferably, the first subset of the first class of biomolecules
electrically connected to a second electronics device (which 	 and the second subset of the first class of biomolecules are
may be the same as or different from the first electronics 	 mutually exclusive. In another version, the first and second
device) that provides a second electromagnetic signal S2 	 subsets of the first class of biomolecules coincide so that the
when a second biomolecule becomes connected to a CNT in 	 system indicates the presence (or probable absence) of only
the second sub-array.	 35 one subset of the second class of biomolecules.
In step 32, an electrically insulating material is provided in	 In step 37 (optional), appearance of the first electromag-
an interstitial space between a first CNT in the first sub-array	 netic signal in the first electronics device is interpreted as
and an adjacent second CNT in the second sub-array, and also 	 indicating that the first subset of the second class of biomol-
between the underlying metal lines, so that a second end of the	 ecule is present in the fluid.
first sub-array CNT and a second end of the second sub-array 40	 In step 38 (optional), appearance of the second electromag-
CNT are exposed. Preferably, the insulating material sepa- 	 netic signal in the second electronics device is interpreted as
rates each CNT from all adjacent CNTs, whether the adjacent 	 indicating that the second subset of the second class of bio-
CNTs are from the same sub-array or from a different sub-	 molecule is present in the fluid. If no analytes in the solution
array. The insulating material may be chosen from among 	 are of interest, the procedure ends here.
SiO,, SiyN,, and suitable polymers, such as epoxy, wax and 45	 In step 39 (optional), reachable through step 34, appear-
parylene.	 ance of a third electromagnetic signal S3 in the corresponding
In step 33, excess insulating material is removed to expose 	 electronics device is interpreted as indicating that a analyte
a second end of one or more of a CNT in the first sub-array and
	 (corresponding to S3) is present in the fluid. The analyte may
of one or more of a second end of a CNT in the second
	
be a biomolecule (such as a nucleic acid, a protein, a nucle-
sub-array, using CMP, mechanical polishing, plasma etching, 50 otide, a peptide, a neurotransmitter, a hormone, an orgainic
wet chemical etching or another suitable material removal 	 molecules (e.g., a pesticide, an amine, a phenol, etc.), or an
procedure.	 inorganic molecules (e.g., heavy metal ion, halide, metal
In step 34 (optional), the exposed surfaces of the device are 	 complex, H 2O2, NO,, etc.). The signal S3 may, for example,
passivated, using non-specific resisting molecules, such as 	 relate electrical current and voltage difference, measured or
polyethylene glycol (PEG), to reduce non-specific adsorption 55 applied, between a CNT second end and a reference elec-
of biomolecules. From step 34, the system moves to step 35 	 trode, which is characteristic for a specific analyte.
or, alternatively, to step 39.	 What is claimed is:
In step 35 (optional), the second end of the first sub-array 	 1. A method for sensing presence of a target biomolecule in
CNT is functionalized by a first selected functionalization 	 a liquid solution, the method comprising:
process, and the second end of the second sub-array CNT is 60	 providing an array of at least first and second carbon nano-
functionalized by a second selected functionalization pro- 	 tubes (CNTs), where a first end of each of the at least first
cess. Functionalization of the second end of the first sub-array 	 and second CNTs is electrically connected by at least
CNT allows a first subset from a first biomolecule class 	 one signal carrying line to, and is oriented substantially
(probe molecule) to attach itself to this second end of the first 	 perpendicular to a surface of, an electronics device that
sub-array CNT, if the subset of probe first biomolecule is 65	 transduces or otherwise provides an identifiable change
present in a fluid medium to which the second end of the first	 in an electrochemical signal when a target biomolecule
sub-array CNT is exposed. Functionalization of the second
	
becomes attached to or interacts with at least one CNT in
US 7,939,734 B1
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8
the array, where the electrochemical signal is at least one 	 carrying line to, and is oriented substantially perpen-
of a differential pulse voltammetry signal, an AC volta- 	 dicular to a surface of, a second electronics device that
mmetry signal, a square wave voltammetry signal, and	 transduces or otherwise provides a change in a second
an electrochemical impedance spectroscopy signal, a	 electrochemical signal of the second sub-array CNT
fast scan cyclic voltammetry signal, a conventional 5	 when a second target biomolecule interacts with or
cyclic voltammetry signal, a conventional potentiom- 	 becomes attachedto a second probe biomolecule located
etry signal, and a conventional amperometry signal; 	 on a second end of the second sub-array CNT, where
providing an electrically insulating material that substan- 	 each of the first and second electrochemical signals is at
tially fills an interstitial space between, and substantially 	 least one of a differential pulse voltammetry signal, an
covers surfaces of, the first and second CNTs and the at 10	 AC voltammetry signal, a square wave voltammetry sig-
least one signal carrying line, and removing a sufficient 	 nal, and an electrochemical impedance signal spectros-
amount of the insulating material to expose a second end	 copy signal, a fast scan cyclic voltammetry signal, a
of the first CNT and a second end of the second CNT, by 	 conventional cyclic voltammetry signal, a conventional
at least one of mechanical polishing, chemical mechani-	 potentiometry signal, and a conventional amperometry
cal polishing, plasma etching and chemical etching, to 15	 signal;
prevent attachment of a probe biomolecule to a side 	 providing an electrically insulating material that substan-
surface of the first and second CNTs; 	 tially fills an interstitial space between the first sub-array
providing a surface passivation layer on exposed surfaces 	 CNT, and the second sub-array CNT, and substantially
of the interstitial insulating material, to suppress attach- 	 covers the first signal carrying line and the second signal
ment of a biomolecule in an adjacent liquid solution to 20	 carrying line, and removing a sufficient amount of the
the surface of the interstitial insulating material; 	 interstitial insulating material to expose the second end
electrochemically etching the surface passivation layer at 	 of the first sub-array CNT and the second end of the
selected locations to expose the second end of the first	 second sub-array CNT, by at least one of mechanical
and second CNTs;	 polishing, chemical mechanical polishing, plasma etch-
functionalizing the second end of the first and second 25	 ing and chemical etching, to insulate the first and second
CNTs with a probe biomolecule that can interact with or 	 sub-array CNTs and to prevent attachment of a probe
become attached to the second end of the first and second
	
biomolecule to a side surface of the first sub-array CNT
CNTs, where the probe biomolecule is at least one of an 	 and to a side surface of the second sub-array CNT;
oligonucleotide, a peptide, a ligand, a protein and an	 providing a surface passivation layer on exposed surfaces
enzyme;	 30	 of the interstitial insulating material, to suppress attach-
immersing the second end of the first and second CNTs in 	 ment of a biomolecule in an adjacent liquid solution to
the liquid solution that may contain at least one target 	 the surface of the interstitial insulating material;
biomolecule;	 electrochemically etching the surface passivation layer at a
when the target biomolecule is present in the solution, 	 first selected location to expose the second end of the
allowing the target biomolecule to interact with or 35	 first sub-array CNT;
become attached to the probe biomolecules at the func- 	 functionalizing the second end of the first sub-array CNT
tionalized second end of the first and second CNTs and 	 with a first probe biomolecule so that the first target
to generate a change in an electrochemical signal of at 	 biomolecule can interact with or become attached to the
least one of the functionalized first and second CNTs; 	 first probe biomolecule at a second end of the first sub-
interpreting lack of receipt of the change in the electro-  40	 array CNT and so that a probe biomolecule that is intro-
chemical signal as indicating that at least one of the 	 duced subsequent to functionalization with the first
following conditions is present: (i) no target biomol- 	 probe biomolecule has no access to the second end of the
ecule is present in the solution and (ii) the target biomol- 	 first sub-array CNT;
ecule is present in the solution in an amount that is less	 electrochemically etching the surface passivation layer at a
than a threshold amount; and	 45	 second selected location to expose the second end of the
interpreting receipt of the change in the electrochemical 	 second sub-array CNT;
signal as indicating that at least one target biomolecule is	 functionalizing the second end of the second sub-array
present in the solution in an amount at least equal to the	 CNT with a second probe biomolecule so that the second
threshold amount.	 target biomolecule can interact with or become attached
2. The method of claim 1, further comprising choosing said 50	 to the second probe biomolecule at a second end of the
insulating material from the group of insulating materials 	 second sub-array CNT;
consisting of SiO,, SiyN,, an epoxy, a wax and a parylene, 	 immersing the second ends of the first sub-array CNT and
where x, y and z are positive numbers. 	 the second sub-array CNT in the liquid solution that may
3. A method for sensing presence of selected first and 	 contain the first target biomolecule and that may contain
second target biomolecules, the method comprising: 	 55	 the second target biomolecule;
providing at least a first carbon nanotube (CNT) in a first 	 when at least one of the first target biomolecule and the
sub-array and at least a second CNT in a second sub- 	 second target biomolecule is present in the solution,
array, where a first end of each first sub-array CNT is 	 allowing at least one of the first target biomolecule and
electrically connected by a first signal carrying line to, 	 the second target biomolecule to interact with or become
and is oriented substantially perpendicular to, a surface 60	 attached to at least one of the respective first probe
of, a first electronics device that transduces or otherwise 	 molecule and second probe molecule on the functional-
provides a change in a first electrochemical signal of the 	 ized second end of at least one of the first sub-array CNT
first sub-array CNT when a first target biomolecule in	 and the second sub-array CNT;
interacts with or becomes attached to a first probe bio- 	 interpreting lack of receipt of change in the first electro-
molecule located on a second end of the first sub-array 65	 chemical signal of the first sub-array functionalized
CNT, and where a first end of each CNT in the second	 CNT at the first electronics device as indicating at least
sub-array is electrically connected by a second signal	 one of: (i) the first target biomoleculeis not present inthe
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solution and (ii) the first target biomolecule is present in
the solution in an amount that is less than a first threshold
amount;
interpreting receipt of change in the first electrochemical
signal of the first sub-array functionalized CNT at the
first electronics device as indicating that the first target
biomolecule is present in the solution in an amount at
least equal to the first threshold amount;
interpreting lack of receipt of change in the second elec-
trochemical signal of the second sub-array functional-
ized CNT at the second electronics device as indicating
at least one of: (i) the second target biomolecule is not
present in the solution and (ii) the second target biomol-
ecule is present in the solution in an amount that is less
than a second threshold amount; and
interpreting receipt of change in the second electrochemi-
cal signal of the second sub-array functionalized CNT at
the second electronics device as indicating that the sec-
ond target biomolecule is present in the solution in an
amount at least equal to the second threshold amount.
4. The method of claim 3, further comprising choosing said
insulating material from the group of insulating materials
consisting of SiOx, SiyNz, an epoxy, a wax and a parylene,
where x, y and z are positive numbers.
5. The method of claim 3, further comprising choosing said
first probe biomolecule to be at least one of an oligonucle-
otide, a peptide, a ligand, a protein and an enzyme.
6.The method of claim 3, further comprising choosing said
second probe biomolecule to be at least one of an oligonucle-
otide, a peptide, a ligand, a protein and an enzyme.
7. The method of claim 1, further comprising choosing said
surface passivation layer to comprise polyethylene glycol.
8. The method of claim 3, further comprising choosing said
first target biomolecule and said second target biomolecule to
be distinguishable from each other.
9. The method of claim 3, further comprising choosing a
signal associated with said first electrochemical signal of the
first sub-array functionalized CNT and a signal associated
with said second electrochemical signal of the second sub-
array functionalized CNT to be distinguishable from each
other.
10. The method of claim 1, further comprising providing
said probe molecule as an NH,-containing molecule that can
form at least one amide bond with a carboxylic acid group at
an exposed second end of at least one of said first CNT and
said second CNT.
11. The method of claim 1, further comprising separating
said first and second CNTs by a separation distance of at least
six times a maximum of a radius of said first CNT and a radius
of said second CNT.
12. The method of claim 3, further comprising choosing
said surface modification layer to comprise polyethylene gly-
col.
13.The method of claim 3, further comprising providing at
least one of said first probe biomolecule and said second
10
probe biomolecule as an NH,-containing molecule that can
form at least one amide bond with a carboxylic acid group on
an exposed second end of at least one of said first sub-array
CNT and said second sub-array CNT.
5 14. The method of claim 3, further comprising separating
said first CNT in said first sub-array by a separation distance
of at least six times a maximum of a radius of said first CNT
from a second CNT in said first sub-array.
15. The method of claim 1, further comprising:
10 measuring a first change of said electrochemical signal
between a first measurement time and a second measure-
ment time;
measuring a second change of said electrochemical signal
between two measurement times that are subsequent to
15	 the first measurement time;
comparing the first change and the second change of said
electrochemical signal with each other; and
when the first change and the second change differ from
each other by at least a threshold value, interpreting this
20	 as indicating that said target biomolecule is present in
said solution.
16. The method of claim 15, further comprising providing
at least one of said first change of said electrochemical signal
and said second change of said electrochemical signal as an
25 irreversible change.
17. The method of claim 3, further comprising providing at
least a third sub-array CNT having a second end that is
exposed by said electrochemical etching but is not function-
alized and does not bind with said first target biomolecule and
so does not bind with said second target biomolecule, to provide
a control signal to indicate if said functionalization by said
first probe biomolecule at said second end of said first sub-
array CNT distinguishes between said binding of said first
target biomolecule and binding of a biomolecule that is not
35 said first target biomolecule.
18.The method of claim 1, further comprising forming said
surface passivation layer using silane chemistry.
19.The method of claim 3, further comprising forming said
surface passivation layer using silane chemistry.
40	 20. The method of claim 3, wherein said functionalization
of said second end of said first sub-array CNT comprises:
providing at least one species of primary amine-terminated
small molecule that forms an amide bond with an unre-
acted COOH group located on said second end of said
45	 first sub-array CNT, before at least one of said second
end of said first sub-array is exposed to said second
probe biomolecule.
21. The method of claim 3, wherein said functionalization
of said second end of said first sub-array CNT comprises:
50 providing said first probe molecules in a close-packed for-
mat at said second end of said first sub-array CNT so that
access of said second probe biomolecules to said second
end of said first sub-array CNT is blocked.
